Speaker Profile

CEO, Pillar Biosciences

Randy Pritchard is the Chief Executive Officer of Pillar Biosciences. He has more than 24 years of experience in corporate and commercial strategy, sales and marketing, and driving growth through innovation. He has held positions of increasing responsibilities, including SVP of US Diagnostics marketing, SVP & Lifecycle Leader at the divisions of POC Diagnostic & Core Reagents, and VP of Marketing at Centralized Diagnostics at Roche Diagnostics. He completed his undergraduate studies at Purdue University and his MBA at Indiana Wesleyan University.

Clinical & Research Tools Showcase:
Pillar Biosciences

Pillar Biosciences is the leader in Decision Medicine™, which is the utilization of highly accurate and sensitive next-generation sequencing (NGS) testing technology to quickly and accurately generate data that optimizes selection of precision therapies for cancer patients.

Leveraging NGS To Enable Localized Decision Medicine
Pillar Biosciences is enabling "Decision Medicine" by enabling localized, more accurate, cost effective and efficient NGS testing.

 Session Abstract – PMWC 2023 Silicon Valley

Showcase Track S2 - January 25 2.45 P.M.-5.00 P.M.,Showcase Track S2 - January 26 1.15 P.M.-4.00 P.M.

The PMWC 2023 Clinical & Research Tools Showcase will provide a 15-minute time slot for selected companies in this space. The Clinical & Research Tools is a showcase for innovative technologies that are used for the analysis of genetic variation and function, helping to advance breakthroughs in genetic health, rare disease conditions on individuals of all ages, complex diseases and cancer care. Next-generation sequencing (NGS) and microarray technologies empower rapidly evolving genomic revolution.